EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark MYGENENEWS was filed as Word mark on 11/06/2008 at the European Union Intellectual Property Office.
It was registered as a trademark on 08/20/2009.
The current status of the mark is "Registration expired".
| Trademark form | Word mark |
| File reference | 007407786 |
| Application date | November 6, 2008 |
| Publication date | December 15, 2008 |
| Entry date | August 20, 2009 |
| Expiration date | November 6, 2018 |
Trademark representatives
Aurora Building, Counterslip
BS1 6BX Bristol
GB
goods and services
9
Computer storage media namely, computer tapes, computer discs and CD-Roms, providing genomic, proteomic and gene expression profile information for use in selecting therapeutics, evaluating efficacy and toxicity of treatments, evaluating treatment progression, prognosing disease or disease progression, and identifying disease heredity risk factors
38
Computer services, namely providing access to databases of life sciences information via global, national and local computer networks in the field of pharmacogenomics, diagnostics, personalized medicine and toxicogenomics; providing access to a patient registry containing personalized health management information accessible via global, national and local computer networks
44
Diagnostic services, including diagnosing, preventing and predicting disease, identifying risk factors of disease, prognostic testing, gene and protein testing, identifying physiological characteristics, and evaluating efficacy of treatment; medical and diagnostic services, including diagnosing, preventing and predicting disease, identifying disease risk factors, diagnostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative care programs, establishing disease treatment based on gene and protein expression and/or activity, evaluating clinical trial progress, and drug monitoring and monitoring of patient health progression; providing genomic, proteomic and gene expression profiles useful in selecting therapeutics, evaluating the efficacy and toxicity of treatments and evaluating treatment progression, prognosing disease or disease progression and identifying disease heredity risk factors; providing a website for patients and medical professionals featuring information about personalized health management, disease, and disease risk assessment services and screening products
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| September 6, 2019 | Extension, Trade mark expired | ||
| May 12, 2015 | Change Representative, Published | ||
| December 15, 2008 | Change Representative, Published |
ID: 11007407786